Clinical Trial Update: Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES [NA]

View source ↗

Summary

This clinical trial update compares P2Y12 antagonist monotherapy to dual antiplatelet therapy after drug-eluting stent placement in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• P2Y12 receptor antagonist

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN